Early Christmas Sale - Ends Soon!
-35% Off Everything
DVA

DaVita Inc. (DVA)

Last Price$152.70.8%
Market Cap$12.8B
LTM Revenue
$12.7B
YoY Growth
+6.3%
3Y CAGR
+3.0%
5Y CAGR
+2.3%
Stock quality & Intrinsic value
5/10
89.6% undervalued

DaVita Inc. Revenue

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
$2,298.6M
$2,973.9M
$4,880.7M
$5,264.2M
$5,660.2M
$6,108.8M
$6,447.4M
$6,792.0M
$8,186.3M
$11.8B
$12.8B
$13.8B
$14.7B
$10.9B
$11.4B
$11.4B
$11.6B
$11.6B
$11.6B
$12.1B
DVA
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for DVA and see if it's the right time to invest.
Dive in

DaVita Inc. (DVA) Revenue comparison analysis

Crunching data... Almost there!

DVA key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is DaVita Inc.'s Revenue?

As of today, DaVita Inc.'s last 12-month Revenue is $12.7B, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is DaVita Inc.'s Revenue growth rate?

Over the last year, DaVita Inc.'s Revenue growth was 6.3%. The average annual Revenue growth rates for DaVita Inc. have been 3.2% over the past three years, 2.3% over the past five years.

3) Is DaVita Inc.'s Revenue growth rate Good?

Over the last year, DaVita Inc.'s Revenue growth was 6.3%, which is higher than industry growth of 0.0%. It indicates that DaVita Inc.'s Revenue growth is Good.

4) How does DaVita Inc.'s Revenue growth rate compare to its peers?

Over the last year, DaVita Inc.'s Revenue growth was 6.3%, which is lower than peer median growth of 8.0%. The list of peers includes HCA, THC, FMS, UHS, SEM, EHC, OPCH, ENSG, ACHC, CHE etc.